The Finnegan Scoring System is crucial for the management of Neonatal Abstinence Syndrome (NAS). NAS occurs when newborns experience withdrawal symptoms due to exposure to drugs, primarily opioids, during pregnancy. The system provides a standardized method for evaluating the severity of these symptoms, guiding treatment plans, and ensuring timely and appropriate care.
